简要介绍C型肝炎病毒治疗方法和未来的前景
Christian Medina1, Alexis Hipólito García1, Francis Isamarg Crespo1
1Institute of Immunology Dr. Nicolás E. Bianco C., Faculty of Medicine, Universidad Central de Venezuela, Caracas 1040, Venezuela.
Current issues in molecular biology
|October 27, 2023
概括
型肝炎病毒 (HCV) 感染是一个全球性的健康问题. 新的直接作用抗病毒药物 (DAA) 提供了较高的持续病毒学反应率,改善了治疗结果并减少了与较旧的基于干扰素的疗法相比副作用.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 型肝炎病毒 (HCV) 感染是一个重大的全球健康问题,可能导致肝硬化和癌症.
- 虽然有些人自然清除HCV,但其他人由于病毒突变或免疫系统缺陷而患上慢性疾病.
- I型和III型干扰素 (IFN) 和它们的信号通路对于抗病毒防御HCV至关重要.
研究的目的:
- 审查C型肝炎病毒 (HCV) 治疗的演变,从早期基于干扰素的治疗到现代直接作用抗病毒药物 (DAA).
- 讨论基因多态化对HCV清除和治疗反应的影响.
- 突出未来的HCV管理研究方向,包括克服耐药性和开发疫苗.
主要方法:
- 对C型肝炎病毒 (HCV) 感染的历史和当前治疗策略的审查.
- 分析免疫因素和基因多态性在HCV病变和治疗结果中的作用.
- 检查抗病毒疗法的进展,包括直接作用抗病毒药物 (DAA).
主要成果:
- 早期基于干扰素的疗法 (IFNα,IFN-RBV,PEGIFNα-RIV) 实现了60%的最大持续病毒学反应 (SVR),并产生了显著的副作用.
- 直接作用抗病毒药物 (DAA) 已经大大提高了SVR率,达到90%以上,副作用最小,即使在儿科患者中也是如此.
- 用DAA和组合疗法改善了共感染 (HBV-HCV,HCV-HIV) 的管理.
结论:
- 直接作用抗病毒药物 (DAA) 是C型肝炎病毒 (HCV) 治疗的重大突破,具有高疗效和更好的安全性.
- 遗传因素 (例如,IFNλ3,IL28B,TLR多态) 在个人对HCV感染和治疗的反应中起着至关重要的作用.
- 未来的研究必须解决DAA耐药性,开发针对特定患者群体的量身定制治疗方法,并创建有效的疫苗,以实现全球HCV根除.
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Retrovirus Life Cycles
46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Viruses with RNA Genomes
35
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
35
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


